Ausgabe 12/2014
Inhalt (12 Artikel)
Bioinformatics for cancer immunotherapy target discovery
Lars Rønn Olsen, Benito Campos, Mike Stein Barnkob, Ole Winther, Vladimir Brusic, Mads Hald Andersen
A multiplex method for the detection of serum antibodies against in silico-predicted tumor antigens
Miriam Reuschenbach, Jonathan Dörre, Tim Waterboer, Jürgen Kopitz, Martin Schneider, Nicoline Hoogerbrugge, Elke Jäger, Matthias Kloor, Magnus von Knebel Doeberitz
Tuftsin-based, EGFR-targeting fusion protein and its enediyne-energized analog show high antitumor efficacy associated with CD47 down-regulation
Wen-Juan Liu, Xiu-Jun Liu, Liang Li, Yi Li, Sheng-Hua Zhang, Yong-Su Zhen
Phenotyping of peripheral blood mononuclear cells of patients with advanced heavily pre-treated adenocarcinoma of the stomach and gastro-esophageal junction
Marie-Cristine Kuehnle, Sebastian Attig, Cedrik M. Britten, Henning Schulze-Bergkamen, Florian Lordick, Goetz von Wichert, Peter Thuss-Patience, Alexander Stein, Martin Schuler, Florian Bassermann, Ugur Sahin, Özlem Türeci
Activation of CD1d-restricted natural killer T cells can inhibit cancer cell proliferation during chemotherapy by promoting the immune responses in murine mesothelioma
Licun Wu, Zhihong Yun, Tetsuzo Tagawa, Luis De la Maza, Matthew Onn Wu, Julie Yu, Yidan Zhao, Marc de Perrot
Interactions between neutrophils and non-small cell lung cancer cells: enhancement of tumor proliferation and inflammatory mediator synthesis
Katja Hattar, Katharina Franz, Michael Ludwig, Ulf Sibelius, Jochen Wilhelm, Jürgen Lohmeyer, Rajkumar Savai, Florentine S. B. Subtil, Gabriele Dahlem, Bastian Eul, Werner Seeger, Friedrich Grimminger, Ulrich Grandel
Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis
Jo A. Tucker, Caroline Jochems, Benjamin Boyerinas, Jonathan Fallon, John W. Greiner, Claudia Palena, Timothy C. Rodell, Jeffrey Schlom, Kwong-Yok Tsang
High placenta-specific 1/low prostate-specific antigen expression pattern in high-grade prostate adenocarcinoma
Roya Ghods, Mohammad-Hossein Ghahremani, Zahra Madjd, Mojgan Asgari, Maryam Abolhasani, Sanaz Tavasoli, Ahmad-Reza Mahmoudi, Maryam Darzi, Parvin Pasalar, Mahmood Jeddi-Tehrani, Amir-Hassan Zarnani
Sequential immune monitoring in patients with melanoma and renal cell carcinoma treated with high-dose interleukin-2: immune patterns and correlation with outcome
David M. Foureau, Asim Amin, Richard L. White, William Anderson, Chase P. Jones, Terry Sarantou, Iain H. McKillop, Jonathan C. Salo
Successful treatment with Ipilimumab and Interleukin-2 in two patients with metastatic melanoma and systemic autoimmune disease
Magnus Pedersen, Rikke Andersen, Peter Nørgaard, Søren Jacobsen, Peter Thielsen, Per thor Straten, Inge Marie Svane
Inconsistencies and questionable reliability of the publication “Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophages-activating, GcMAF” by Yamamoto et al
Ana Ugarte, Gauthier Bouche, Lydie Meheus
Retraction Note to: Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF
Nobuto Yamamoto, Hirofumi Suyama, Hiroaki Nakazato, Nobuyuki Yamamoto, Yoshihiko Koga